Which documented finding in a client’s history increases the risk for cholecystitis?

The documented finding in a client's history that increases the risk for cholecystitis is the female client taking norgestimate-ethinyl estradiol daily. This combination of a female gender and the use of hormonal contraceptives, particularly those that contain estrogen, has been associated with an increased risk of gallbladder disease, including cholecystitis. Estrogen can influence cholesterol saturation in bile and may decrease gallbladder motility, contributing to the formation of gallstones, which can lead to cholecystitis.

Hormonal influences, especially in women, are significant when discussing gallbladder disease because the risk is notably higher in females, particularly during reproductive years when hormonal contraceptives are often utilized. The relationship between estrogen and increased cholesterol levels in bile, combined with reduced gallbladder contractility, creates an environment where gallstones can form, ultimately leading to inflammation and potential complications such as cholecystitis.

In contrast, the other options provided do not carry the same level of association with an increased risk of cholecystitis. High protein intake does not particularly contribute to gallbladder disease, nor does low fat consumption in older adults. Additionally, while low physical activity can contribute to various